No bias score yet for this article.
Uses 4 AI models - Takes ~10 seconds
A BNP Paribas analyst thinks Lumentum’s stock can climb another 40% as it ramps production capacity for ultrahigh-powered lasers and capitalizes on AI-driven demand for its products.
Source
MarketWatch
Opens original article in a new tab
Asia-Pacific markets rose after a sharp drop in oil prices eased investor concerns, following signs of de-escalation in the Middle East conflict.
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
The consumer price index fell to 1.3% last month, its lowest level since March 2022 and below the central bank's 2% target. It was down from 1.5% in January.
In a document that resembles an IPO prospectus, OpenAI highlighted the risk of its dependence on Microsoft and of supply disruptions at TSMC.